Mercia Asset Management has sold The Native Antigen Company, a medical research company, to LGC, a portfolio company of Astorg and Cinven, for £18m.
Mercia Asset Management has sold The Native Antigen Company, a medical research company, to LGC, a portfolio company of Astorg and Cinven, for £18m.